Crossmark

Clinical Pharmacokinetics of Antitubercular Drugs in the Overweight and Obese Population: Implications for Dosage Adjustments

Published Online: 2025-01-10

Published Print: 2025-02

Authors

Prager, Marlene https://orcid.org/0000-0002-7326-8310
al Jalali, Valentin

Zeitlinger, Markus
Funding

Funding for this research was provided by:

Medical University of Vienna
License Information

Text and Data Mining valid from 2025-01-10

Version of Record valid from 2025-01-10
More Information

Article History

Accepted: 21 October 2024

First Online: 10 January 2025

Declarations

:

: Open access funding provided by Medical University of Vienna. No sources of funding were used to assist with the preparation of this review.

: The authors do not have any conflict of interest directly relevant to the content of this review. Markus Zeitlinger is an Editorial Board member of Clinical Pharmacokinetics. Markus Zeitlinger was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.

: Marlene Prager, Valentin al Jalali, and Markus Zeitlinger contributed to the concept and writing of the paper.

: Not applicable. This review article does not involve any primary data collection from human participants.

: Not applicable.

: Not applicable.

: Not applicable. The data used in this review is sourced from publicly available literature.

: Not applicable. This review does not involve the use of any software code that requires sharing.

Document is current